Skip to main navigation Skip to search Skip to main content

罗汉果甜苷V的合成生物学研究进展

Translated title of the contribution: Synthetic biology for the synthesis of mogroside V - a review
  • Zemin Sun
  • , Bo Lü*
  • , Yongjun Feng*
  • *Corresponding author for this work
  • Beijing Institute of Technology

Research output: Contribution to journalReview articlepeer-review

Abstract

Mogroside V, a component with high content and sweetness in mogrosides, has many pharmacological activities such as relieving cough, reducing sputum, anti-cancer, anti-oxidation, regulating blood sugar, making it a natural nonsugar sweetener with therapeutic functions, and showing a broad market prospect. However, the limited resources and high extraction costs have restricted its widespread use. The rapid development of synthetic biology has provided a new idea for the production of plant natural products. The low-cost and large-scale production will be realized through the construction of a microbial cell factory for mogroside V. Here, we briefly introduce the structure and pharmacological activity of mogroside V, and review progress in applying synthetic biology for its synthesis, and also discuss the challenges faced by the current research, to provide a reference for further studies on the biosynthesis of mogroside V.

Translated title of the contributionSynthetic biology for the synthesis of mogroside V - a review
Original languageChinese (Traditional)
Pages (from-to)2017-2028
Number of pages12
JournalShengwu Gongcheng Xuebao/Chinese Journal of Biotechnology
Volume36
Issue number10
DOIs
Publication statusPublished - 25 Oct 2020
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Synthetic biology for the synthesis of mogroside V - a review'. Together they form a unique fingerprint.

Cite this